Cargando…
Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263898/ https://www.ncbi.nlm.nih.gov/pubmed/35798529 http://dx.doi.org/10.1136/bmjopen-2022-061691 |
_version_ | 1784742851767173120 |
---|---|
author | Tanner, Amanda E Goldenberg, Tamar Erausquin, Jennifer Toller Mertus, Sulianie Jibriel, Mohammed Sheikh Eldin Barrington, Clare |
author_facet | Tanner, Amanda E Goldenberg, Tamar Erausquin, Jennifer Toller Mertus, Sulianie Jibriel, Mohammed Sheikh Eldin Barrington, Clare |
author_sort | Tanner, Amanda E |
collection | PubMed |
description | INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context. METHODS AND ANALYSIS: This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted. ETHICS AND DISSEMINATION: As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v |
format | Online Article Text |
id | pubmed-9263898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-92638982022-07-25 Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol Tanner, Amanda E Goldenberg, Tamar Erausquin, Jennifer Toller Mertus, Sulianie Jibriel, Mohammed Sheikh Eldin Barrington, Clare BMJ Open Public Health INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context. METHODS AND ANALYSIS: This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted. ETHICS AND DISSEMINATION: As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v BMJ Publishing Group 2022-07-07 /pmc/articles/PMC9263898/ /pubmed/35798529 http://dx.doi.org/10.1136/bmjopen-2022-061691 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Public Health Tanner, Amanda E Goldenberg, Tamar Erausquin, Jennifer Toller Mertus, Sulianie Jibriel, Mohammed Sheikh Eldin Barrington, Clare Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title | Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title_full | Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title_fullStr | Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title_full_unstemmed | Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title_short | Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
title_sort | measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263898/ https://www.ncbi.nlm.nih.gov/pubmed/35798529 http://dx.doi.org/10.1136/bmjopen-2022-061691 |
work_keys_str_mv | AT tanneramandae measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol AT goldenbergtamar measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol AT erausquinjennifertoller measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol AT mertussulianie measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol AT jibrielmohammedsheikheldin measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol AT barringtonclare measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol |